EG 427 Appoints New Members To Board of Directors and Scientific Advisory Board

March 24, 2023

Venture and pharmaceutical industry veteran, Sundar Kodiyalam, becomes a new member on Board of Directors. 

Leading expert in herpes virus vector research, Gregory A. Smith, Ph.D., joins Scientific Advisory Board. 

 

Read Full Press Release in English or in French


Recent posts

EG 427 announces attendance to multiple upcoming conferences in fall 2023
EG 427 announces attendance to multiple upcoming conferences in fall 2023

read more >

EG 427 presents positive preclinical data on lead asset EG110A at International Continence Society meeting
EG 427 presents positive preclinical data on lead asset EG110A at International Continence Society meeting

read more >

EG 427 announces final Series A closing, achieving €18 million in total funds raised
EG 427 announces final Series A closing, achieving €18 million in total funds raised

read more >

EG 427 announces that Dr. Greg Sarek, VP Research will be presenting at the 3rd annual Next Generation Gene Therapy Vectors conference
EG 427 announces that Dr. Greg Sarek, VP Research will be presenting at the 3rd annual Next Generation Gene Therapy Vectors conference

read more >

EG 427 appoints Ralph Laufer as new member to Board of Directors
EG 427 appoints Ralph Laufer as new member to Board of Directors

read more >

×

Essential Cookies

These cookies are necessary for the website to function and cannot be turned off. They are used, for example, to maintain the contents of the user's basket. You can set your browser to block these cookies, but then the website will not function prope

Always active

Analytical cookies

These cookies allow you to count visits and traffic sources. Thanks to these files, it is known which pages are more popular and how the website visitors navigate. All information these cookies collect is anonymous.